logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (vii) All inpatient clients, age distribution by primary drug (%)

Substance<1515-1920-2425-2930-3435-3940-4445+Mean ageAge knownAge not known
Opioids0.13.819.129.822.012.47.55.430.91632243
Cocaine0.14.518.925.021.116.19.54.831.319466
Stimulants0.514.330.623.013.16.95.06.528.1364533
Hypnotics and sedatives0.53.311.413.812.712.410.235.739.7135915
Hallucinogens2.013.739.223.57.80.05.97.827.3510
Volatile substances9.738.619.114.99.14.92.41.222.93291
Cannabis 0.821.631.721.810.16.03.84.226.3363720
Other substances 0.35.821.423.016.09.88.215.332.811291
Total0.47.921.926.418.410.96.97.130.328418119

Notes:

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, FR, CY, LV,HU, AT, RO, SK, FI, SE, UK, HR, TR.   

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010